Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 139

1.

Selecting targets for cancer prevention: where do we go from here?

Szabo E.

Nat Rev Cancer. 2006 Nov;6(11):867-74. Review.

PMID:
17036038
2.

Raloxifene in breast cancer prevention.

Gennari L, Merlotti D, Paola VD, Nuti R.

Expert Opin Drug Saf. 2008 May;7(3):259-70. doi: 10.1517/14740338.7.3.259 . Review.

PMID:
18462184
3.

Tamoxifen versus raloxifene in the prevention of breast cancer.

Wickerham DL.

Eur J Cancer. 2002 Nov;38 Suppl 6:S20-1. No abstract available.

PMID:
12409060
4.
5.

Chemoprevention of breast cancer: recommendations and rationale.

[No authors listed]

Am Fam Physician. 2003 Mar 15;67(6):1309-14. Review. No abstract available.

6.

Rationale for using raloxifene to prevent both osteoporosis and breast cancer in postmenopausal women.

Lee WL, Chao HT, Cheng MH, Wang PH.

Maturitas. 2008 Jun 20;60(2):92-107. doi: 10.1016/j.maturitas.2008.04.009. Review.

PMID:
18534794
7.

Prevention of breast cancer: current state of the science and future opportunities.

Uray IP, Brown PH.

Expert Opin Investig Drugs. 2006 Dec;15(12):1583-600. Review.

PMID:
17107283
8.

Chemoprevention of breast cancer.

Thomsen A, Kolesar JM.

Am J Health Syst Pharm. 2008 Dec 1;65(23):2221-8. doi: 10.2146/ajhp070663. Review.

PMID:
19020189
9.

Raloxifene and the prevention of breast cancer.

Bevers TB.

Expert Opin Pharmacother. 2006 Nov;7(16):2301-7. Review.

PMID:
17059385
10.
11.

SERMs for the treatment and prevention of breast cancer.

Swaby RF, Sharma CG, Jordan VC.

Rev Endocr Metab Disord. 2007 Sep;8(3):229-39. Review.

PMID:
17440819
13.

Risks, benefits, and effects on quality of life of selective estrogen-receptor modulator therapy in postmenopausal women at increased risk of breast cancer.

Ganz PA, Land SR.

Menopause. 2008 Jul-Aug;15(4 Suppl):797-803. doi: 10.1097/gme.0b013e31817be9af. Review.

PMID:
18596601
14.

Hormonal interventions to prevent hormonal cancers: breast and prostate cancers.

Dunn BK, Ford LG.

Eur J Cancer Prev. 2007 Jun;16(3):232-42. Review.

PMID:
17415094
15.

Raloxifene and breast cancer.

Lorraine J.

CMAJ. 2001 Oct 2;165(7):888. No abstract available.

16.
17.

Drug insight: breast cancer prevention and tissue-targeted hormone replacement therapy.

Labrie F.

Nat Clin Pract Endocrinol Metab. 2007 Aug;3(8):584-93. Review.

PMID:
17643129
18.

Tamoxifen or raloxifene in postmenopausal women for prevention of breast cancer: a tale of two choices--counterpoint.

Fabian C.

Cancer Epidemiol Biomarkers Prev. 2007 Nov;16(11):2210-2. No abstract available.

19.

Clinical trials in cancer prevention: current results and perspectives for the future.

Greenwald P.

J Nutr. 2004 Dec;134(12 Suppl):3507S-3512S. Review.

20.

SERMs: meeting the promise of multifunctional medicines.

Jordan VC.

J Natl Cancer Inst. 2007 Mar 7;99(5):350-6. Review.

PMID:
17341726

Supplemental Content

Support Center